Rtw Investments as of Sept. 30, 2019
Portfolio Holdings for Rtw Investments
Rtw Investments holds 60 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rocket Pharmaceuticals (RCKT) | 11.4 | $193M | 17M | 11.61 | |
| Alnylam Pharmaceuticals (ALNY) | 8.4 | $142M | 1.8M | 80.42 | |
| Ptc Therapeutics I (PTCT) | 7.3 | $124M | 3.7M | 33.82 | |
| Dicerna Pharmaceuticals | 5.3 | $89M | 6.2M | 14.36 | |
| Bristol Myers Squibb (BMY) | 4.7 | $79M | 1.6M | 50.71 | |
| Stoke Therapeutics (STOK) | 4.1 | $69M | 3.4M | 20.68 | |
| Milestone Pharmaceuticals (MIST) | 3.8 | $64M | 3.5M | 18.12 | |
| Zimmer Holdings (ZBH) | 3.3 | $55M | 403k | 137.27 | |
| Masimo Corporation (MASI) | 3.3 | $55M | 371k | 148.79 | |
| Sarepta Therapeutics (SRPT) | 3.2 | $55M | 724k | 75.32 | |
| Achillion Pharmaceuticals | 3.0 | $50M | 14M | 3.60 | |
| Mirati Therapeutics | 2.8 | $46M | 593k | 77.91 | |
| Homology Medicines | 2.6 | $44M | 2.4M | 18.10 | |
| Axonics Modulation Technolog (AXNX) | 2.5 | $41M | 1.5M | 26.92 | |
| Vericel (VCEL) | 2.4 | $40M | 2.6M | 15.14 | |
| Establishment Labs Holdings Ord (ESTA) | 2.3 | $39M | 2.0M | 18.91 | |
| Myokardia | 2.2 | $38M | 725k | 52.15 | |
| Adverum Biotechnologies | 2.0 | $34M | 6.3M | 5.45 | |
| Translate Bio | 1.9 | $31M | 3.1M | 9.91 | |
| Bellus Health | 1.6 | $27M | 4.2M | 6.43 | |
| Agenus | 1.4 | $24M | 9.2M | 2.58 | |
| Apyx Medical Corporation (APYX) | 1.4 | $23M | 3.4M | 6.77 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 1.3 | $21M | 3.7M | 5.76 | |
| Insulet Corporation (PODD) | 1.1 | $18M | 111k | 164.93 | |
| La Jolla Pharmaceuticl Com Par | 1.1 | $18M | 2.0M | 8.80 | |
| Arvinas Ord (ARVN) | 1.0 | $17M | 810k | 21.55 | |
| Axsome Therapeutics (AXSM) | 1.0 | $17M | 846k | 20.24 | |
| Johnson & Johnson (JNJ) | 0.9 | $15M | 117k | 129.38 | |
| MiMedx (MDXG) | 0.9 | $15M | 3.0M | 4.90 | |
| Castle Biosciences (CSTL) | 0.8 | $14M | 745k | 18.09 | |
| Dermtech Ord ord (DMTKQ) | 0.7 | $13M | 2.4M | 5.24 | |
| Transmedics Group (TMDX) | 0.7 | $12M | 503k | 23.75 | |
| Quidel Corporation | 0.6 | $11M | 177k | 61.35 | |
| Regenxbio Inc equity us cm (RGNX) | 0.6 | $10M | 291k | 35.60 | |
| Quotient | 0.6 | $10M | 1.3M | 7.77 | |
| D Fluidigm Corp Del (LAB) | 0.6 | $9.8M | 2.1M | 4.63 | |
| Natera (NTRA) | 0.6 | $9.4M | 288k | 32.80 | |
| Protagonist Therapeutics (PTGX) | 0.5 | $9.2M | 762k | 12.01 | |
| Odonate Therapeutics Ord | 0.5 | $8.8M | 340k | 26.03 | |
| Arbutus Biopharma (ABUS) | 0.5 | $8.5M | 5.6M | 1.53 | |
| Silk Road Medical Inc Common | 0.5 | $8.0M | 245k | 32.53 | |
| Exagen (XGN) | 0.5 | $7.9M | 512k | 15.49 | |
| Principia Biopharma | 0.5 | $7.7M | 271k | 28.24 | |
| Brainsway Ltd- (BWAY) | 0.5 | $7.6M | 835k | 9.11 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $7.3M | 991k | 7.38 | |
| Chardan Healthcare Acquisition | 0.4 | $7.2M | 600k | 11.97 | |
| Uniqure Nv (QURE) | 0.3 | $5.7M | 145k | 39.36 | |
| Inmode Ltd. Inmd (INMD) | 0.3 | $5.4M | 250k | 21.51 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $5.0M | 6.9M | 0.72 | |
| Personalis Ord (PSNL) | 0.2 | $3.7M | 255k | 14.67 | |
| Caredx (CDNA) | 0.2 | $3.5M | 155k | 22.61 | |
| Argenx Se (ARGX) | 0.2 | $3.6M | 32k | 113.97 | |
| Vivus Inc conv | 0.2 | $2.9M | 4.0M | 0.73 | |
| Clearside Biomedical (CLSD) | 0.1 | $2.4M | 3.7M | 0.63 | |
| Solid Biosciences | 0.1 | $1.5M | 146k | 10.34 | |
| Motus Gi Hldgs Incorporated | 0.1 | $1.3M | 676k | 1.98 | |
| Neuronetics (STIM) | 0.1 | $1.4M | 168k | 8.31 | |
| Optinose (OPTN) | 0.0 | $615k | 88k | 7.00 | |
| Livongo Health | 0.0 | $262k | 15k | 17.47 | |
| 10x Genomics Inc Cl A (TXG) | 0.0 | $252k | 5.0k | 50.40 |
